Cyan Formulators Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-07-2024
- Paid Up Capital ₹ 0.44 M
as on 16-07-2024
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 217.32 Cr
as on 16-07-2024
- Revenue 27855.15%
(FY 2023)
- Profit 874670.04%
(FY 2023)
- Ebitda 55.75%
(FY 2023)
- Net Worth 1960.47%
(FY 2023)
- Total Assets 249.22%
(FY 2023)
About Cyan Formulators
The Corporate was formerly known as Arpit Invesrments Pvt Ltd. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.44 M.
The company has closed loans amounting to ₹217.32 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shankerlal Sharma, Surya Pandey, and Shashikant Chavan serve as directors at the Company.
- CIN/LLPIN
U65990MH1989PTC050900
- Company No.
050900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai 400 072.A.R.29.09.01, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cyan Formulators?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shankerlal Sharma  | Director | 01-Jun-2005 | Current |
| Surya Pandey | Director | 08-Jan-2003 | Current |
| Shashikant Chavan | Additional Director | 23-Aug-2021 | Current |
Financial Performance of Cyan Formulators.
Cyan Formulators Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27855.15% increase. The company also saw a substantial improvement in profitability, with a 874670.04% increase in profit. The company's net worth Soared by an impressive increase of 1960.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cyan Formulators?
In 2023, Cyan Formulators had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Invent Assets Securitisation And Reconstruction Private Limited Creation Date: 02 Jun 1998 | ₹217.32 Cr | Satisfied |
How Many Employees Work at Cyan Formulators?
Cyan Formulators has a workforce of 1 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cyan Formulators, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyan Formulators's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
